We are live on ! Find out more
PCVX icon

Vaxcyte
PCVX

223 hedge funds and large institutions have $6.51B invested in Vaxcyte in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 86 increasing their positions, 69 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

236% more call options, than puts

Call options by funds: $9.9M | Put options by funds: $2.94M

131% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 16

26% more capital invested

Capital invested by funds: $5.17B → $6.51B (+$1.34B)

25% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 69

10% more funds holding

Funds holding: 202 → 223 (+21)

8% more funds holding in top 10

Funds holding in top 10: 13 → 14 (+1)

0.88% more ownership

Funds ownership: 108.03% → 108.91% (+0.88%)

Holders
223
Holders Change
+21
Holders Change %
+10.4%
% of All Funds
3.25%
Holding in Top 10
14
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+7.69%
% of All Funds
0.2%
New
37
Increased
86
Reduced
69
Closed
16
Calls
$9.9M
Puts
$2.94M
Net Calls
+$6.96M
Net Calls Change
+$6.35M

Top Buyers

1
BlackRock
BlackRock
New York
+$60M
2
Morgan Stanley
Morgan Stanley
New York
+$34.5M
3
DGM
Darwin Global Management
Jersey
+$30.1M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$23.5M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$20M

Top Sellers

1
MVM
Medicxi Ventures Management
Jersey
-$53.5M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$32.3M
3
FAM
Fred Alger Management
New York
-$22M
4
NIP
Nicholas Investment Partners
California
-$18.1M
5
B
Braidwell
Connecticut
-$17.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACP
76
Acuta Capital Partners
California
$7.37M -$190K -3,649 -3%
Walleye Capital
77
Walleye Capital
New York
$7.15M +$5.92M +113,921 New
NIP
78
Nicholas Investment Partners
California
$6.95M -$18.1M -349,285 -76%
Manulife (Manufacturers Life Insurance)
79
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$6.6M +$636K +12,249 +13%
SEI Investments
80
SEI Investments
Pennsylvania
$6.49M -$939K -18,071 -15%
California Public Employees Retirement System
81
California Public Employees Retirement System
California
$6.16M -$260K -4,999 -5%
CS
82
Credit Suisse
Switzerland
$6.14M +$602K +11,591 +13%
Marshall Wace
83
Marshall Wace
United Kingdom
$5.73M -$1.9M -36,490 -29%
OM
84
Opaleye Management
Massachusetts
$5.65M – – –
Neuberger Berman Group
85
Neuberger Berman Group
New York
$5.41M +$1.04M +19,976 +30%
CM
86
Castleark Management
Illinois
$5.35M +$1.49M +28,630 +51%
California State Teachers Retirement System (CalSTRS)
87
California State Teachers Retirement System (CalSTRS)
California
$5.17M -$27.9K -537 -0.6%
UBS AM
88
UBS AM
Illinois
$5.12M +$362K +6,975 +9%
Legal & General Group
89
Legal & General Group
United Kingdom
$5.02M +$238K +4,573 +6%
Citigroup
90
Citigroup
New York
$4.96M -$858K -16,527 -17%
First Trust Advisors
91
First Trust Advisors
Illinois
$4.88M +$2.33M +44,923 +137%
GTC
92
Ghost Tree Capital
New York
$4.4M -$3.64M -70,000 -50%
Jane Street
93
Jane Street
New York
$4.39M +$3.63M +69,928 New
AA
94
ALPS Advisors
Colorado
$4.1M -$208K -4,010 -6%
State of Wisconsin Investment Board
95
State of Wisconsin Investment Board
Wisconsin
$3.59M -$667K -12,848 -18%
New York State Common Retirement Fund
96
New York State Common Retirement Fund
New York
$3.43M +$60.8K +1,170 +2%
RJA
97
Raymond James & Associates
Florida
$3.24M -$123K -2,363 -4%
Mirae Asset Global Investments
98
Mirae Asset Global Investments
South Korea
$3.21M +$15.4K +296 +0.6%
LCM
99
Laurion Capital Management
New York
$3.14M – – –
MIM
100
MetLife Investment Management
New Jersey
$3.09M – – –
2 3
4
5 6

PCVX Hedge Fund Activity: Q4 2023 in Review

223 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Vaxcyte (PCVX) for Q4 2023, worth a combined $6.51B — up 26% from $5.17B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new PCVX positions and 16 closed out — a net gain of 21 holders — while 86 added to existing stakes and 69 trimmed.

The largest buyer was BlackRock, adding an estimated $60M. The largest seller was Medicxi Ventures Management, exiting entirely with an estimated $53.5M sold.

  • 223 institutional investors held Vaxcyte (PCVX) as of Q4 2023, up from 202 in Q3 2023.
  • Funds reported $6.51B of Vaxcyte stock for Q4 2023, up 26% quarter-over-quarter.
  • 37 funds opened new Vaxcyte positions in Q4 2023 and 16 closed out, a net change of +21 holders.
  • The largest Vaxcyte buyer in Q4 2023 was BlackRock, an estimated $60M added.
  • The largest Vaxcyte seller in Q4 2023 was Medicxi Ventures Management, an estimated $53.5M sold.

Based on aggregated 13F filings for Q4 2023.